Made O'Meter

Discover where a brand or product originates

RINVOQ

ownerAbbVie Inc. (USA)

originUnited States

RINVOQ is owned by AbbVie Inc., headquartered in the United States. Yes. The ultimate owner of RINVOQ, AbbVie Inc., is headquartered in the United States.

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical diseases.

AbbVie Deutschland GmbH & Co. KG

Products from RINVOQ (2)

RINVOQ 30 mg upadacitinib · Pharmaceutical – Immunomodulator
RINVOQ 15 mg Upadacitinib · Other – Pharmaceutical (JAK inhibitor)

Alternatives to RINVOQ

Teva · Teva Pharmaceutical Industries Ltd. (Israel)
Sandoz · Sandoz Group AG (Switzerland)
Cinfa · Infarco, S.A. (Spain)
Ratiopharm · Teva Pharmaceutical Industries Ltd. (Israel)
EG (EuroGenerici) · STADA Arzneimittel AG (Germany)
HEXAL · Sandoz Group AG (Switzerland)

Sources: abbvie.com, rinvoq.com

Check another product

disclaimer

poweredBy